Clinical Trial Update: Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update on long-term outcomes for patients with severe pemphigus treated with rituximab. The study reports clinical and biological evalua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Pemphigus | Phase 3 | Status: COMPLETED